Akorn (AKRX) gets FDA approval for a generic version of vancomycin, an antibiotic used against...

|By:, SA News Editor

Akorn (AKRX) gets FDA approval for a generic version of vancomycin, an antibiotic used against life-threatening infections. It expects to market the drug in the first half of 2009, and sees annual sales of $150M. Shares of the $175M firm are up 28% premarket to $2.50.